Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Learn when to do a Backdoor Roth in 2026, including optimal timing around income, limits, and market conditions.
15,255 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A leveraged Treasury ETF illustrates how daily rebalancing can crush long-term returns. TMF turned $10,000 into $1,52...
As of mid-2026, the U.S. housing market remains tight. Boomers hold many homes and aren’t selling fast, while Millenn...
Bank of America says Micron Technology is trading at a sub-10x forward multiple despite a structural shift toward AI-...
ON Semiconductor slumped about 20% after unveiling an all-stock purchase of Synaptics, triggering questions about dil...
Rising AI adoption is outpacing hardware and data-center capacity, forcing cloud providers to ration compute. The bot...
JPMorgan Chase stands out for its scale, diversified earnings, and capital strength, reinforcing its role as a steady...
Investors are testing a new approach to fund life’s milestones—without tapping the core retirement nest egg. The cele...
NVIDIA’s market value dips below the $5 trillion threshold as traders reassess AI demand and supply dynamics. Analyst...
Tesla accelerates margin gains in Q1 2026 as Rivian pushes its R2 strategy through partnerships and new products, hig...
A leading economist contends the FED will keep rates steady through year-end, challenging current market bets and sha...
Samsung and Dunamu say they were listed as members of the OUSD stablecoin consortium without official consultation. T...